Patents by Inventor Bryan J. Perry

Bryan J. Perry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine
    Patent number: 8217049
    Abstract: The use of type V phosphodiesterase inhibitors as a novel independent therapeutic modality in the treatment of exercise induced pulmonary hemorrhage in equine is described. The type V phosphodiesterase inhibitor is injected into the horse intravenously as a stand-alone agent from about one-half hour to about seven (7) days prior to the onset of strenuous exercise.
    Type: Grant
    Filed: May 1, 2007
    Date of Patent: July 10, 2012
    Assignee: ANOxA Corp.
    Inventor: Bryan J. Perry
  • Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine
    Publication number: 20070254885
    Abstract: The use of type V phosphodiesterase inhibitors as a novel independent therapeutic modality in the treatment of exercise induced pulmonary hemorrhage in equine is described. The type V phosphodiesterase inhibitor is injected into the horse intravenously as a stand-alone agent from about one-half hour to about seven (7) days prior to the onset of strenuous exercise.
    Type: Application
    Filed: May 1, 2007
    Publication date: November 1, 2007
    Inventor: Bryan J. Perry
  • Use of nitric oxide in the treatment of exercised induced pulmonary hemorrhaging in equine
    Patent number: 5765548
    Abstract: The administration of nitric oxide in controlled doses to horses during high intensity exercise is described. The nitric oxide is beneficial to prevent exercised induced pulmonary hemorrhaging by reducing pulmonary artery pressure with a concomitant compensating reduction in pulmonary vascular resistance. The nitric oxide is either administered to the equine through inhalation during exercise or via a stand alone nitric oxide gas source followed by an intramuscular injection of a nitric oxide augmenter prior to exercise.
    Type: Grant
    Filed: May 7, 1996
    Date of Patent: June 16, 1998
    Inventor: Bryan J. Perry